Haleon invests $12m in Panadol
Summary by The Express Tribune
1 Articles
1 Articles
Haleon invests $12m in Panadol
Haleon Pakistan has announced a fresh investment of $12 million to expand its manufacturing capacity, focusing on scaling up Panadol production. The move aims to meet growing domestic demand and ensure consistent availability of the widely used pain relief medicine. Speaking at Haleon's head office, CEO and General Manager Qawi Naseer said the company's 2022 demerger from GSK enabled it to focus exclusively on consumer healthcare. This shift has…
·Pakistan
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium